Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: Risk factors and rates of occurrence

Clinical Microbiology and Infection

Volumn 15, Issue 7, 2009, Pages 670-679

  Tibaldi, Cecelia ^a,c   Cappello, N ^a   Latino, M A ^b   Masuelli, G ^a   Marini, S ^a   Benedetto, C ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Sant'Anna Hospital   (Italy)

^c NONE   (Italy)

Author keywords

Bacterial vaginosis; Candida; Hormonal status; Sexual behaviour; STD; Vaginal flora

Indexed keywords

ESTROGEN; IRRITANT AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BARRIER CONTRACEPTION; CANDIDA; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GRAM POSITIVE BACTERIUM; HORMONAL CONTRACEPTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENOPAUSE; MICROBIAL IDENTIFICATION; MORBIDITY; MYCOPLASMA HOMINIS; ORAL CONTRACEPTION; PERSONAL HYGIENE; PREPUBERTY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEXUAL ABUSE; SEXUAL BEHAVIOR; SYMPTOMATOLOGY; TISSUE CULTURE; UREAPLASMA UREALYTICUM; UTERINE CERVICITIS; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR; VAGINITIS;

BACTERIA (MICROORGANISMS); CANDIDA; CHLAMYDIA TRACHOMATIS; ESCHERICHIA COLI; MYCOPLASMA HOMINIS; NEGIBACTERIA; POSIBACTERIA; TRICHOMONAS VAGINALIS; UREAPLASMA UREALYTICUM;

ADOLESCENT; ADULT; AGED; ANIMALS; CANDIDA; CERVIX UTERI; CHILD; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MENARCHE; MENOPAUSE; MIDDLE AGED; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; TRICHOMONAS VAGINALIS; VAGINA; VAGINAL DISEASES; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 68249141485     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02842.x     Document Type: Article

References (38)

1. Vermillon ST, Homes MM, Soper DE. Adolescents and sexually transmissible diseases. Obstet Gynecol Clin North Am 2000; 27: 163-179.
2. Goldenberg RL, Andrews WW, Yuan AC et al. Sexually transmitted diseases and adverse outcomes of pregnancy. Clin Perinatol 1997; 24: 23-41.
3. Penney GC. Preventing infective sequelae of abortion. Hum Reprod 1997; 12 (suppl11): 107-112.
4. Sweet RL. Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis 1995; 20(suppl 2): S271-S275.
5. Amsel R, Totten PA, Spigel CA et al. Nonspecific vaginitis diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74: 14-22.
6. Kokotos F. Vulvovaginitis. Pediatr Rev 2006; 27: 116-117.
7. Gupta K, Hillier SL, Hooton TM et al. Effects of contraceptive method on the vaginal microbial flora: A prospective evaluation. J Infect Dis 2000; 181: 595-601.
8. Piippo S, Lenko H, Vuento R. Vulvar symptoms in paediatric and adolescent patients. Acta Paediatr 2000; 89: 431-435.
9. Jaquiery A, Stylianopoulos A, Hogg S et al. Vulvovaginitis: Clinical features, aetiology, and microbiology of the genital tract. Arch Dis Child 1999; 81: 64-67.
10. Banerjee K, Curtis E, de San Lazzaro C et al. Low prevalence of genital candidiasis in children. Eur J Clin Microbiol Infect Dis 2004; 23: 696-698.
11. Rein MF. Vulvovaginitis and cervicitis. In: Mandell GL, Bennett JE, Dolin R, eds, Principle and practice of infectious diseases. Philadelphia: Churchill Livingstone, 2000: 1218-1234.
12. Ferrer J. Vaginal candidosis: Epidemiological and etiological factors. Int J Gynecol Obstet 2000; 71: S21-S27.
13. Schlicht MJ, Lovrich SD, Sartin JS et al. High prevalence of genital Mycoplasmas among sexually active young adults with urethritis or cervicitis symptoms in la Crosse, Wisconsin. J Clin Microbiol 2004; 42: 4636-4640.
14. Newton ER, Piper JM, Shin RN et al. Predictors of the vaginal microflora. Am J Obstet Gynecol 2001; 184: 845-855.
15. Iwasaka T, Wada T, Kidera Y et al. Hormonal status and Mycoplasma colonization in the female genital tract. Obstet Gynecol 1986; 68: 263-266.
16. Mardth PA, Westrom L. T-Mycoplasma in the genito-urinary tract of the female. Acta Path Scand 1970; 78: 367.
17. Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis. 2001-2004 national health and nutrition examination survey data. Obstet Gynecol 2007; 109: 114-120.
18. Cauci S, Driussi S, De Santo D et al. Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women. J Clin Microbiol 2002; 40: 2147-2152.
19. Moi H. Prevalence of bacterial vaginosis and its association with genital infections, inflammation, and contraceptive methods in women attending sexually transmitted disease and primary health clinics. Int J STD AIDS 1990; 1: 86-94.
20. Nilsson U, Hellberg D, Skoubnikova M et al. Sexual risk factors associated with bacterial vaginosis and Chlamydia trachomatis infection. Sex Transm Dis 1997; 24: 241-246.
21. Bradshaw CS, Morton AN, Garland SM et al. Higher-risk behavioural practices associated with bacterial vaginosis compared with vaginal candidiasis. Obstet Gynecol 2005; 106: 105-114.
22. Holzman C, Leventhal J, Qui H et al. Factors linked to bacterial vaginosis in non pregnant women. Am J Public Health 2001; 91: 1664-1670.
23. Schwebke JR, Desmond RA, Oh MK. Predictors of bacterial vaginosis in adolescent women who douche. Sex Transm Dis 2004; 31: 433-436.
24. Skarin A, Sylwan J. Vaginal lactobacilli inhibiting growth of Gardnerella vaginalis, Mobiluncus and other bacterial species cultured from vaginal content of women with bacterial vaginosis. APMIS 1986; 94: 399-403.
25. Peipert JF. Genital chlamydial infections. N Engl J Med 2003; 349: 2424-2430.
26. Spinillo A, Bernuzzi AM, Cevini C et al. The relationship of bacterial vaginosis, candida and trichomonas infection to symptomatic vaginitis in postmenopausal women attending a vaginitis clinic. Maturitas 1997; 27: 253-260.
27. Hillier S, Lau RJ. Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy. Clin Infect Dis 1997; 25(suppl 2): S123-S126.
28. Kent LH. Epidemiology of vulvovaginitis. Am J Obstet Gynecol 1991; 165: 1168-1176.
29. Graves A, Gardner WA. Pathogenicity of Trichomonas vaginalis. Clin Obstet Gynecol 1993; 36: 145-152.
30. Garber GE, Lemchuk-Favel LT, Bowie WR. Isolation of a cell-detaching factor of Trichomonas vaginalis. J Clin Microbiol 1989; 27: 1548-1553.
31. Gerbase AC, Rowley JT, Heymann DHL et al. Global prevalence and incidence estimates of selected curable STDs. Sex Transm Inf 1998; 74(suppl 1): S12-S16.
32. Center for Disease Control and Prevention. STD surveillance 2004. Atlanta, GA: US. Department of Health and Human Sciences, September 2005.
33. Nelson AL. The impact of contraceptive methods on the onset of symptomatic vulvovaginal candidiasis within the menstrual cycle. Am J Obstet Gynecol 1997; 176: 1376-1380.
34. Spinillo A, Capuzzo E, Nicola S et al. The impact of oral contraception on vulvovaginal candidiasis. Contraception 1995; 51: 293-297.
35. Beaten JM, Nyange PM, Richardson BA et al. Hormonal contraception and risk of sexually transmitted disease acquisition: Results from a prospective study. Am J Obstet Gynecol 2001; 185: 380-385.
36. Richey C, Macaluso M, Hook E. Determinants of reinfection with Chlamydia trachomatis. Sex Transm Dis 1999; 26: 4-11.
37. Park B, Stergachis A, Scholes D et al. Contraceptive methods and the risk of Chlamydia trachomatis infection in young women. Am J Epidemiol 1995; 142: 771-778.
38. Soper DE, Brockwell NJ, Dalton HP. Evaluation of the effects of a female condom on the female lower genital tract. Contraception 1991; 44: 21-29.